Related Experiment Video
Updated: Oct 18, 2026

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
Validation of Head and Neck EASI Severity Strata Against vIGA-AD in Atopic Dermatitis
Amalie Thorsti Møller Rønnstad1, Yuki M F Andersen1, Ann Hærskjold1
1Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
Background:
Head-and-neck (H&N) Eczema Area and Severity Index (EASI) sub-scores are increasingly reported, but their clinical interpretation relative to the validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD) remains unclear.
Objective:
Define H&N EASI severity strata anchored to vIGA-AD and evaluate convergent validity and interrater reliability.
Methods:
Twenty-two dermatologists evaluated photographs of 21 patients with H&N AD using the H&N EASI and vIGA-AD. H&N EASI severity strata were derived based on the empirical distribution within vIGA-AD. Kendall's tau (τ) and Spearman's correlation coefficient (SCC) assessed convergent validity, and intraclass correlation coefficients (ICC) evaluated interrater reliability.
Results:
H&N EASI scores aligned with vIGA-AD (0, "Clear"; 0.1-0.6, "Almost clear"; 0.7-1.7, "Mild"; 1.8-3.0, "Moderate"; and 3.1-4.8, "Severe"), showing almost perfect agreement (weighted Cohen's κ = 0.83 [95% CI, 0.80-0.86], P < 0.001). H&N EASI and vIGA-AD scores were strongly correlated (τ = 0.74 [95% CI, 0.71-0.77]; SCC = 0.86 [95% CI, 0.83-0.88], both P < 0.001). Interrater reliability was moderate for H&N EASI (0.73 [95% CI, 0.60-0.85]) and vIGA-AD (0.61 [95% CI, 0.46-0.77]) (both P < 0.001).
Conclusions:
H&N EASI severity strata provide a reliable and clinically meaningful assessment of H&N AD, aligning with facial vIGA-AD and enabling evaluation beyond global assessment.
Related Concept Videos
Assessment of Airway, Skin Color, and Use of Accessory Muscles
Introduction
The initial evaluation of a patient's respiratory system...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma III: Clinical Manifestations
